Jonathan McNeill, President and COO at CRESCENT BIOPHARMA, INC. (CBIO), sold 4,570 shares at $17.90 ($77K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Scheduled sale ($77k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.90 | 731 | $13K | 16.9% |
| 2 | $16.71 | 3,839 | $64K | 83.1% |
| Total | $16.90 avg | 4,570 | $77K | 100% |
| Filing → |
| DYN | SELL | 2024-06-11 | $114K | — | Filing → |
| DYN | SELL | 2024-05-17 | $143K | — | Filing → |
| DYN | SELL | 2024-03-13 | $5.2M | — | Filing → |